CAMZYOS caps 2.5 mg 28 pce

7680684770012 CH-68477 C01EB24 02.99.0.

Reimbursement limitations:

CAMZYOS.01

Le remboursement nécessite une garantie de prise en charge des frais par l’assureur maladie, après …

CAMZYOS caps 2.5 mg 28 pce
CAMZYOS caps 2.5 mg 28 pce
CAMZYOS caps 2.5 mg 28 pce
1 / 3
google

Details

Product number
6847701
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
mavacamtenum 2.5 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 0.525 mg.

Articles (1)

Camzyos 2.5 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/09/2025
Patient information leaflet
Français
19/09/2025
Patient information leaflet
Italien
19/09/2025
Professional SmPC
Allemand
19/09/2025
Professional SmPC
Français
19/09/2025
Professional SmPC
Italien
19/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
0.525 MG Substance HBESI

Reimbursement information

Public price
CHF 1454.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2023

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
68477
Drug name
Camzyos, Hartkapseln
Galenic form
KAHA
ATC Code
C01EB24
Authorization status
Z
Dispensation category
B
First authorization
25/04/2023
Authorization expiration date
24/04/2028
IT number
02.99.0.
Domain
Human medicine
Field of application
symptomatische obstruktive hypertrophe Kardiomyopathie

Packaging details

Description (FR)
CAMZYOS caps 2.5 mg 28 pce
Description (DE)
CAMZYOS Kaps 2.5 mg 28 Stk
Market launch
25/04/2023
Narcotic (BTM)
No

Other packaging sizes

CAMZYOS caps 5 mg 28 pce
28 KAP
GTIN: 7680684770036
View
CAMZYOS caps 10 mg 28 pce
28 KAP
GTIN: 7680684770043
View
CAMZYOS caps 15 mg 28 pce
28 KAP
GTIN: 7680684770050
View